Company profileMixed portfolio#407 of 1,318 in Pakistan✓ No DRAP alerts

M SUUA PHARMA INTERNATIONAL

Mixed portfolio · 14 pharmaceutical brands of 40 registrations

40 registered products 14 pharmaceutical brands 59 distinct molecules 0 DRAP alerts

Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

M SUUA PHARMA INTERNATIONAL is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 40 product registrations across 59 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin11 brands

Cefixime2 brands

Cefotaxime2 brands

Ciprofloxacin2 brands

Fluorouracil1 brand

Miconazole ...... 20 Mg1 brand

Miconazole1 brand

Famotidine1 brand

Mupirocin ...... 20 Mg1 brand

Mupirocin1 brand

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official28 products · Rs 89.31 – Rs 6,698.18

Median across source: Rs 387.41

Regulatory record

✓

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

MEDISURE LABORATORIES PAKISTAN (PVT.) LTD.27 shared molecules

NABIQASIM INDUSTRIES (PVT) LTD.25 shared molecules

Atco Pharma International (Pvt) Ltd24 shared molecules

HIGH - Q INTERNATIONAL23 shared molecules

GETZ PHARMA PAKISTAN (PVT) LTD.23 shared molecules

Wilshire Laboratories (Private) Limited23 shared molecules

HILTON PHARMA (PVT) LIMITED23 shared molecules

SHAIGAN PHARMACEUTICALS (PVT) LTD.22 shared molecules

BIO LABS (PVT) LTD.21 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD21 shared molecules

Get the full profile for M

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included